Pharmacokinetics and pharmacodynamics of isoniazid in patients with intermediate resistance

Int J Tuberc Lung Dis. 2017 Jan 1;21(1):121-123. doi: 10.5588/ijtld.16.0689.

Authors

Abdullah Alsultan¹, Charles A Peloquin²

Affiliations

¹ Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
² Infectious Disease Pharmacokinetics Laboratory, University of Florida College of Pharmacy and Emerging Pathogens Institute, Gainesville, FL, USA. peloquin@cop.ufl.edu.

PMID: 28157477
DOI: 10.5588/ijtld.16.0689

No abstract available

Publication types

Letter
Comment

MeSH terms

Antitubercular Agents*
Humans
Isoniazid*
Tuberculosis

Substances

Antitubercular Agents
Isoniazid